Jubilant Pharma establishes dollar curve
Debut issuer Jubilant Pharma ventured out to the international bond market on September 29, netting $300m from its first dollar-denominated transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: